Article
Novartis Ophthalmics and QLT Inc. were awarded with the Helen Keller Prize for Innovation in Eye Care for their development of Visudyne (verteporfin for injection) therapy.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.